Skip to content
WeighLab

Invyncible vs Mevo Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Invyncible

Provider comparison

Cost-first shoppers who want compounded GLP-1 combo programs (with B12/glycine) alongside brand Wegovy/Zepbound on one platform.

Semaglutide / month
$149/mo0.45 mg dose, compounded with glycine + B12
Tirzepatide / month
$180/mo2.5 mg weekly, 4-week program, compounded
Index 59/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Invyncible pricing Read review

Mevo Health

Provider comparison

Patients who want a named physician-led network and can confirm their medication price and plan term before paying.

Semaglutide / month
From $199/moCompounded injection; dose and plan term require confirmation
Tirzepatide / month
From $259/moCompounded injection; dose and plan term require confirmation
Index 59/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Mevo Health pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 59/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Invyncible
46 states plus DC
Mevo Health
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Invyncible

Mevo Health

Semaglutide / month
Invyncible: $149/mo0.45 mg dose, compounded with glycine + B12
Mevo Health: From $199/moCompounded injection; dose and plan term require confirmation
Tirzepatide / month
Invyncible: $180/mo2.5 mg weekly, 4-week program, compounded
Mevo Health: From $259/moCompounded injection; dose and plan term require confirmation
Semaglutide / year (modeled)
Invyncible: $1,788
Mevo Health: $2,388
Tirzepatide / year (modeled)
Invyncible: $2,160
Mevo Health: $3,108
State availability
Invyncible: 46 states plus DC
Mevo Health: Coverage not published
Oral / sublingual option listed
Invyncible: Yes
Mevo Health: Not listed
Brand-name access listed
Invyncible: Yes
Mevo Health: Not confirmed
Provider facts checked
Invyncible: October 2026
Mevo Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Invyncible

Cost-first shoppers who want compounded GLP-1 combo programs (with B12/glycine) alongside brand Wegovy/Zepbound on one platform.

Reasons to consider it

  • Publishes itemized dollar prices for seven compounded programs plus two brand options directly on the site, no signup required, with the mg vial size named in every dose option
  • Sells FDA-approved brand Wegovy ($1,750/mo) and Zepbound ($1,540/mo) alongside compounded options
  • Names all six compounding pharmacies with street addresses and phone numbers and lets the patient choose which one fills the prescription

What to weigh up

  • Every listed price is shown as a discount off a much higher struck-through 'list' price, and the page invites further negotiation — reads as permanent anchor pricing
  • The entry figure is the smallest vial: plain compounded semaglutide runs $192.50, $262.50 and $350 across its three vial sizes, and the FAQ confirms cost rises with dose
  • The six named pharmacies carry no 503A or 503B designation anywhere, and no medical director is named

Compounded drugs are not FDA-approved. Understand the medication options.

Check Invyncible pricing Read the full Invyncible review

Mevo Health

Patients who want a named physician-led network and can confirm their medication price and plan term before paying.

Reasons to consider it

  • Named, board-certified Medical Director (Dr. David Wasef) heading a stated provider network
  • LegitScript verification badge displayed
  • Publishes the FDA compounded-medication disclaimer verbatim

What to weigh up

  • The $199/$259 floors are not tied to a specific dose or plan length on the public page
  • Plans include monthly, quarterly and six-month options; confirm the full charge
  • The dispensing pharmacy is not identified before ordering

Compounded drugs are not FDA-approved. Understand the medication options.

Check Mevo Health pricing Read the full Mevo Health review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

InvyncibleMevo Health
Normalized Cost/Month
Invyncible:
60/100
Mevo Health:
55/100
Price Transparency
Invyncible:
30/100
Mevo Health:
78/100
Nationwide Access
Invyncible:
66/100
Mevo Health:
24/100
Formulation Options
Invyncible:
79/100
Mevo Health:
66/100
Clinical Oversight
Invyncible:
70/100
Mevo Health:
73/100
Contract Flexibility
Invyncible:
61/100
Mevo Health:
63/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to InvyncibleAlternatives to Mevo Health
More provider matchups
CoreAge Rx vs InvyncibleCoreAge Rx vs Mevo Health
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.